Products for Research Use Only
RegisterLogin

HCV-IN-37

CAT: 0804-HY-144110Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-144110Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
HCV-IN-37 (Compound 3d) is a potent inhibitor of HCV. HCV-IN-37 is orally available and long-lasting in rat plasma after oral administration to rats by a single dose of 15 mg/kg. The high potency of active derivative HCV-IN-37 is primarily driven by the inhibitory effect on the virus entry stage[1].
CAS Number
2425804-98-2
UNSPSC
12352005
Target
HCV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hcv-in-37.html
Solubility
10 mM in DMSO
Smiles
N#CC1=CC=C(N2CCN(C)CCC2)C=C1CN3CCN(C(C4=CC=C(F)C=C4)C5=CC=C(F)C=C5)CC3
Molecular Formula
C31H35F2N5
Molecular Weight
515.64
References & Citations
[1]Wang Y, et al. Design, Synthesis, and Biological Evaluation of 2- ((4-Bisarylmethyl-piperazin-1-yl) methyl) benzonitrile Derivatives as HCV Entry Inhibitors. J Med Chem. 2022 Feb 10;65 (3) :2107-2121.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P4741LL-37 (37-1)
HY-128306HCV-IN-50
HY-144107HCV-IN-34
HY-P0162HCV-IN-4
HY-138305-01HCV-IN-31
HY-147764HCV-IN-40
HY-144109HCV-IN-36
HY-18564HCV-IN-3
HY-W103964-01HCV-IN-47
HY-136267-01HCV-IN-30

Alternative Products

CatalogName
GTR19185055-01HCV-IN-37
PR-1409-SHCV NS3 genotype 1c 37 kDa
PR-1417-lHCV NS5 genotype 1a 37 kDa
GTR18878298HCV NS3 genotype 2c 37 kDa
JBS-PR-1417-SHCV NS5 genotype 1a, 37 kDa (S pack)
JBS-PR-1409-SHCV NS3 genotype 1c, 37 kDa (S pack)
JBS-PR-1417-LHCV NS5 genotype 1a, 37 kDa (L pack)
JBS-PR-1408-SHCV NS3 genotype 2c, 37 kDa (S pack)
JBS-PR-1408-LHCV NS3 genotype 2c, 37 kDa (L pack)
JBS-PR-1409-LHCV NS3 genotype 1c, 37 kDa (L pack)

Popular Products